RCT Files Malpractice Claims Against Nixon Peabody and Mintz Levin
On July 22, 2014, RCT filed a lawsuit in New York federal court against Mintz Levin, Nixon Peabody, and former insiders of Neogenix Oncology, a publicly reporting biotechnology company. As alleged in the complaint, the company’s former CFO, with the knowledge and consent of the company’s outside counsel, paid finder fees for sales of Neogenix stock, regardless of whether the “finders” were licensed to sell securities. This practice violated securities laws, triggered an SEC inquiry, and caused the company’s bankruptcy.
Prior results do not guarantee a similar outcome